Europe Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase Synthesis, Chip-based Synthesis), By Service, By Application, By End-use, By Research Phase, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation and Scope
                       1.1.1. Market definitions
                   1.2. Information Procurement
                       1.2.1. Market formulation & data visualization
                       1.2.2. Data validation & publishing
                   1.3. Research Assumptions
                   1.4. Research Methodology
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis
                           1.7.1.1. Approach 1: Commodity flow approach
                   1.8. List of Secondary Sources
                   1.9. Global Market: CAGR Calculation
                   1.10. Objectives
                       1.10.1. Objective 1
                       1.10.2. Objective 2
Chapter 2. Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Trends and Outlook
                   3.3. Market Dynamics
                       3.3.1. Market Driver Analysis
                           3.3.1.1. Rising investment in the synthetic biology market
                           3.3.1.2. Advent of enzymatic DNA synthesis process
                           3.3.1.3. Technological advancements in the DNA synthesis platforms
                           3.3.1.4. Declining price of DNA synthesis & sequencing
                       3.3.2. Market Restraint Analysis
                           3.3.2.1. Lack of skilled professionals
                           3.3.2.2. Misuse of gene synthesis
                   3.4. Industry Analysis Tools
                       3.4.1. Porter’s Five Forces Analysis
                       3.4.2. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
                       3.4.3. COVID-19 Impact Analysis
Chapter 4. Europe Gene Synthesis (Research Use) Market: Method Estimates & Trend Analysis
                   4.1. Method Movement Analysis & Market Share, 2022 & 2030
                   4.2. Europe Gene Synthesis (Research Use) Market Estimates & Forecast, By Method (USD Million)
                   4.3. Solid-Phase Synthesis
                       4.3.1. Solid Phase Synthesis Market, 2018 - 2030 (USD Million)
                   4.4. Chip Based Synthesis
                       4.4.1. Chip-Based Synthesis Market, 2018 - 2030 (USD Million)
                   4.5. PCR-based Enzyme Synthesis
                       4.5.1. PCR-based based Enzyme Synthesis Market, 2018 - 2030 (USD Million)
Chapter 5. Europe Gene Synthesis (Research Use) Market: Service Estimates & Trend Analysis
                   5.1. Service Movement Analysis & Market Share, 2022 & 2030
                   5.2. Europe Gene Synthesis (Research Use) Market Estimates & Forecast, By Service (USD Million)
                   5.3. Antibody DNA Synthesis
                       5.3.1. Antibody DNA Synthesis Market, 2018 - 2030 (USD Million)
                   5.4. Viral DNA Synthesis
                       5.4.1. Viral DNA Synthesis Market, 2018 - 2030 (USD Million)
                   5.5. Others
                       5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Europe Gene Synthesis (Research Use) Market: Application Estimates & Trend Analysis
                   6.1. Application Movement Analysis & Market Share, 2022 & 2030
                   6.2. Europe Gene Synthesis (Research Use) Market Estimates & Forecast, By Application (USD Million)
                   6.3. Gene & Cell Therapy Development
                       6.3.1. Gene & Cell Therapy Development Market, 2018 - 2030 (USD Million)
                   6.4. Vaccine Development
                       6.4.1. Vaccine Development Market, 2018 - 2030 (USD Million)
                   6.5. Others
                       6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Europe Gene Synthesis (Research Use) Market: Research Phase Estimates & Trend Analysis
                   7.1. Research Phase Movement Analysis & Market Share, 2022 & 2030
                   7.2. Europe Gene Synthesis (Research Use) Market Estimates & Forecast, By Research Phase (USD Million)
                   7.3. Preclinical
                       7.3.1. Preclinical Market, 2018 - 2030 (USD Million)
                   7.4. Clinical
                       7.4.1. Clinical Market, 2018 - 2030 (USD Million)
Chapter 8. Europe Gene Synthesis (Research Use) Market: End-use Estimates & Trend Analysis
                   8.1. End-use Movement Analysis & Market Share, 2022 & 2030
                   8.2. Europe Gene Synthesis (Research Use) Market Estimates & Forecast, By End-use (USD Million)
                   8.3. Biopharmaceutical & Pharmaceutical Companies
                       8.3.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
                   8.4. Academic & Government Research Institutes
                       8.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
                   8.5. Contract Research Organizations
                       8.5.1. Contract Research Organizations Market, 2018 - 2030 (USD Million)
Chapter 9. Europe Gene Synthesis (Research Use) Market: Region Estimates & Trend Analysis
                   9.1. Europe Gene Synthesis (Research Use) Market: Region Outlook
                   9.2. Europe
                       9.2.1. Europe Gene Synthesis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       9.2.2. Germany
                           9.2.2.1. Key Country Dynamics
                           9.2.2.2. Target Disease Prevalence
                           9.2.2.3. Competitive Scenario
                           9.2.2.4. Germany gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
                       9.2.3. France
                           9.2.3.1. Key Country Dynamics
                           9.2.3.2. Target Disease Prevalence
                           9.2.3.3. Competitive Scenario
                           9.2.3.4. France gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
                       9.2.4. UK
                           9.2.4.1. Key Country Dynamics
                           9.2.4.2. Target Disease Prevalence
                           9.2.4.3. Competitive Scenario
                           9.2.4.4. UK gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
                       9.2.5. Italy
                           9.2.5.1. Key Country Dynamics
                           9.2.5.2. Target Disease Prevalence
                           9.2.5.3. Competitive Scenario
                           9.2.5.4. Italy gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
                       9.2.6. Spain
                           9.2.6.1. Key Country Dynamics
                           9.2.6.2. Target Disease Prevalence
                           9.2.6.3. Competitive Scenario
                           9.2.6.4. Spain gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
                       9.2.7. Denmark
                           9.2.7.1. Key Country Dynamics
                           9.2.7.2. Target Disease Prevalence
                           9.2.7.3. Competitive Scenario
                           9.2.7.4. Denmark gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
                       9.2.8. Sweden
                           9.2.8.1. Key Country Dynamics
                           9.2.8.2. Target Disease Prevalence
                           9.2.8.3. Competitive Scenario
                           9.2.8.4. Sweden gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
                       9.2.9. Norway
                           9.2.9.1. Key Country Dynamics
                           9.2.9.2. Target Disease Prevalence
                           9.2.9.3. Competitive Scenario
                           9.2.9.4. Norway gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
                       9.2.10. Netherland
                           9.2.10.1. Key Country Dynamics
                           9.2.10.2. Target Disease Prevalence
                           9.2.10.3. Competitive Scenario
                           9.2.10.4. Netherland gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
                       9.2.11. Switzerland
                           9.2.11.1. Key Country Dynamics
                           9.2.11.2. Target Disease Prevalence
                           9.2.11.3. Competitive Scenario
                           9.2.11.4. Switzerland gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
                   10.1. Company Categorization
                   10.2. Strategy Mapping
                   10.3. Company Share Analysis, 2022
                   10.4. Company Profiles/Listing
                       10.4.1. GenScript
                           10.4.1.1. Overview
                           10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.4.1.3. Method Benchmarking
                           10.4.1.4. Strategic Initiatives
                       10.4.2. Azenta, Inc. (GENEWIZ)
                           10.4.2.1. Overview
                           10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.4.2.3. Method Benchmarking
                           10.4.2.4. Strategic Initiatives
                       10.4.3. Boster Biological Technology
                           10.4.3.1. Overview
                           10.4.3.2. Method Benchmarking
                           10.4.3.3. Strategic Initiatives
                       10.4.4. Twist Bioscience
                           10.4.4.1. Overview
                           10.4.4.2. Method Benchmarking
                           10.4.4.3. Strategic Initiatives
                       10.4.5. ProteoGenix, Inc
                           10.4.5.1. Overview
                           10.4.5.2. Method Benchmarking
                           10.4.5.3. Strategic Initiatives
                       10.4.6. Biomatik.
                           10.4.6.1. Overview
                           10.4.6.2. Method Benchmarking
                           10.4.6.3. Strategic Initiatives
                       10.4.7. ProMab Biotechnologies, Inc.
                           10.4.7.1. Overview
                           10.4.7.2. Method Benchmarking
                           10.4.7.3. Strategic Initiatives
                       10.4.8. Thermo Fisher Scientific, Inc
                           10.4.8.1. Overview
                           10.4.8.2. Method Benchmarking
                           10.4.8.3. Strategic Initiatives
                       10.4.9. Integrated DNA Technologies, Inc. (Danaher)
                           10.4.9.1. Overview
                           10.4.9.2. Method Benchmarking
                           10.4.9.3. Strategic Initiatives
                       10.4.10. OriGene Technologies, Inc.
                           10.4.10.1. Overview
                           10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.4.10.3. Method Benchmarking
                           10.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Europe gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 4 Europe gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 5 Europe gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 6 Europe gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 7 Europe gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 8 UK gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 9 UK gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 10 UK gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 11 UK gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 12 UK gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 13 Germany gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 14 Germany gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 15 Germany gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 16 Germany gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 17 Germany gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 18 France gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 19 France gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 20 France gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 21 France gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 22 France gene synthesis (research-use) market by Research Phase2018 - 2030 (USD Million)
Table 23 Italy gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 24 Italy gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 25 Italy gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 26 Italy gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 27 Italy gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 28 Spain gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 29 Spain gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 30 Spain gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 31 Spain gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 32 Spain gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 33 Denmark gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 34 Denmark gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 35 Denmark gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 36 Denmark gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 37 Denmark gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 38 Sweden gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 39 Sweden gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 40 Sweden gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 41 Sweden gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 42 Sweden gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 43 Norway gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 44 Norway gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 45 Norway gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 46 Norway gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 47 Norway gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 48 Netherland gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 49 Netherland gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 50 Netherland gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 51 Netherland gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 52 Netherland gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 53 Switzerland gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 54 Switzerland gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 55 Switzerland gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 56 Switzerland gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 57 Switzerland gene synthesis (research-use) market by Research Use, 2018 - 2030 (USD Million)
Table 58 Participant’s overview
Table 59 Financial performance
Table 60 Key companies undergoing expansions
Table 61 Key companies undergoing acquisitions
Table 62 Key companies undergoing collaborations
Table 63 Key companies launching new products/services
Table 64 Key companies undergoing partnerships
Table 65 Key companies undertaking other strategies

List of Figures

Fig. 1 Europe gene synthesis (research-use) market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modeling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Segment snapshot
Fig. 16 Competitive landscape snapshot
Fig. 17 Market trends & outlook
Fig. 18 Porter’s five force analysis
Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal )
Fig. 20 Europe gene synthesis (research use) market: method outlook key takeaways
Fig. 21 Europe gene synthesis (research use) market: method movement analysis
Fig. 22 Solid-phase synthesis market, 2018 - 2030 (USD Million)
Fig. 23 Chip-based synthesis market, 2018 - 2030 (USD Million)
Fig. 24 PCR-based enzyme synthesis market, 2018 - 2030 (USD Million)
Fig. 25 Europe gene synthesis (research use) market: services outlook and key takeaways
Fig. 26 Europe gene synthesis (research use) market: services movement analysis
Fig. 27 Antibody DNA synthesis market, 2018 - 2030 (USD Million)
Fig. 28 Viral DNA synthesis market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Europe gene synthesis (research use) market: application outlook and key takeaways
Fig. 31 Europe gene synthesis (research use) market: application movement analysis
Fig. 32 Gene & cell therapy development market, 2018 - 2030 (USD Million)
Fig. 33 Vaccine development market, 2018 - 2030 (USD Million)
Fig. 34 Others market, 2018 - 2030 (USD Million)
Fig. 35 Europe gene synthesis (research use) market: End-use outlook key takeaways
Fig. 36 Europe gene synthesis (research use) market: end-use movement analysis
Fig. 37 Biotechnology and pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 38 Academic and government research institutes market, 2018 - 2030 (USD Million)
Fig. 39 Contract research organizations market, 2018 - 2030 (USD Million)
Fig. 40 Europe gene synthesis (research use) market: research phase outlook and key takeaways
Fig. 41 Europe gene synthesis (research use) market: research phase movement analysis
Fig. 42 Preclinical market, 2018 - 2030 (USD Million)
Fig. 43 Clinical market, 2018 - 2030 (USD Million)
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 Regional marketplace: Key takeaways
Fig. 46 Europe gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 UK gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Cancer incidence, 2022
Fig. 50 Key country dynamics
Fig. 51 Germany gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Cancer incidence, 2018-2030
Fig. 53 Key country dynamics
Fig. 54 France gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Cancer incidence 2018-2030
Fig. 56 Key country dynamics
Fig. 57 Spain gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Cancer incidence 2022
Fig. 59 Key country dynamics
Fig. 60 Italy gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Cancer incidence 2022
Fig. 62 Key country dynamics
Fig. 63 Denmark gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Target disease prevalence
Fig. 65 Key country dynamics
Fig. 66 Sweden gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Cancer incidence in Sweden
Fig. 68 Key country dynamics
Fig. 69 Norway gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Cancer incidence in Norway 2022
Fig. 71 Key country dynamics
Fig. 72 Switzerland gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Cancer prevalence in Switzerland 2022
Fig. 74 Key country dynamics
Fig. 75 Netherlands gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Cancer prevalence in Netherlands 2022
Fig. 77 Market participant categorization
Fig. 78 Company market share analysis, 2022
Fig. 79 Strategic framework